Cancer Immunotherapy Market Size, Share, Report By 2032
The global cancer immunotherapy market reached USD 100 billion in 2022 and is expected to hit around USD 275.11 billion by 2032, poised to grow …
To give accurate information is our responsibly.
The global cancer immunotherapy market reached USD 100 billion in 2022 and is expected to hit around USD 275.11 billion by 2032, poised to grow …
The global drug and gene delivery devices market size reached USD 400 billion in 2022 and is projected to hit USD 812.95 billion by 2032 …
The global generic drugs market size reached USD 464.98 billion in 2023 and is estimated to surpass around USD 776.78 billion by 2033, notable at …
The global drug of abuse testing market size was valued at US$ 4.90 billion in 2022 and is projected to hit US$ 9.15 billion by …
The global asthma drugs market is predicted to reach over USD 34.28 billion by 2030, growing at a CAGR of 5.2% during the forecast period …
The global generic sterile injectable market size was valuedat US$ 77.41 billion in 2021 and is expected to reach US$ 203.66 billion by 2030, growing at …
Due to the COVID-19 pandemic, it has been assessed that the major stake of the medical devices business that comprises dental care devices, imaging devices, …
The global electrophysiology devices market is projected to hit around USD 10.72 billion by 2027 with a remarkable CAGR of 8.6% from 2022 to 2027. …
Integration of artificial intelligence (AI) is picking up pace in drug development. AI is used for various aspects, starting from the discovery of compounds exhibiting …
AstraZeneca has identified an additional novel target for its drug development portfolio for idiopathic pulmonary fibrosis (IPF), allowing BenevolentAI, a leading clinical-stage AI-enabled drug discovery …